On February 1, 2022 SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, reported that management will present at the following upcoming investor conferences (Press release, SpringWorks Therapeutics, FEB 1, 2022, View Source [SID1234607577]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2022 Guggenheim Oncology Conference on Thursday, February 10 from 10:00-10:25 am ET.
Cowen 42nd Annual Health Care Conference on Monday, March 7 from 1:30-2:00 pm ET.
Barclays Global Healthcare Conference on Wednesday, March 16 from 9:30-10:00 am ET.
Webcasts of these events will be available on the Events & Presentations page within the Investors & Media section of the company’s website at View Source Replays of the webcasts will be available on SpringWorks’ website for a limited time following each conference.